DBVT — DBV Technologies S.A.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1613780 ·
Last close
$17.42
Market Cap
$1.03B
52W High
$23.04
52W Low
$15.61
ADV30
246,277
Next earnings
2026-07-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -47,900,000 | -47,600,000 | 266,400,000 | 229,200,000 | 58,500,000 |
| Dec 2025 | 0 | — | -45,048,000 | -44,829,000 | 233,718,000 | 194,167,000 | 64,948,000 |
| Sep 2025 | 0 | — | -34,277,000 | -33,164,000 | 110,495,000 | 69,837,000 | 57,641,000 |
| Jun 2025 | 0 | — | -41,110,000 | -41,875,000 | 143,429,000 | 103,207,000 | 57,205,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-150,483,000
Investing CF
$-1,169,000
Financing CF
$365,082,000
CapEx
$-928,000
Dividends Paid
—
Buybacks
$-152,000
EPS Diluted TTM
$-4.60
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-440,700,000
Inventory
—
Receivables
$15,100,000
ST Investments
—
EBIT TTM
$-168,335,000
Pretax Income TTM
$-166,777,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,736,000
EBITDA
$-165,162,000
Free Cash Flow
$-87,206,000
Enterprise Value
$807,569,792
Total Cash
$229,200,000
Total Debt
$6,100,000
Shares Out
59,186,686
Trailing EPS
$-4.50
Book Value
$3.52
ROE
-158.9%
ROA
-66.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -147,054,000 | -146,947,000 | 233,718,000 | 64,948,000 | — | -121,181,000 |
| Dec 2024 | 0 | -116,590,000 | -113,918,000 | 65,658,000 | 38,271,000 | — | -104,474,000 |
| Dec 2023 | 0 | -76,433,000 | -72,726,000 | 182,986,000 | 42,799,000 | — | -79,653,000 |
| Dec 2022 | 0 | -96,631,000 | -96,274,000 | 246,518,000 | 52,065,000 | — | -55,666,000 |
TTM Snapshot
Revenues TTM
$3,533,000
NetIncome TTM
$-49,852,000
OpCashFlow TTM
$0
Assets (Latest)
$65,658,000
Forward EPS
$-0.49
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| COAG | Hemab Therapeutics Holdings, Inc. | $1.17B | $24.98 | — |
| MGTX | MeiraGTx Holdings plc | $888.13M | $9.59 | — |
| DBVTF | DBV Technologies S.A. | $1.26B | $4.26 | — |
| CGEM | Cullinan Therapeutics, Inc. | $841.98M | $13.70 | — |
| IMTX | Immatics N.V. | $1.28B | $9.38 | — |
News headlines (Yahoo Finance, 1h cache)
DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?
2026-06-15 11:59 · Yahoo
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
2026-06-12 15:14 · Yahoo
DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
2026-06-09 11:00 · Yahoo
DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026
2026-06-08 20:35 · Yahoo
DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
2026-06-05 20:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week
2026-06-05 15:06 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
2026-06-04 15:08 · Yahoo
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026
2026-06-03 20:31 · Yahoo
DBV Technologies Announces the Results of its 2026 Combined General Meeting
2026-06-03 20:30 · Yahoo
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
2026-06-02 23:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.